Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) FCF Margin (2016 - 2026)

Dexcom has reported FCF Margin over the past 17 years, most recently at 37.67% for Q1 2026.

  • Quarterly FCF Margin rose 2833.0% to 37.67% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 29.67% through Mar 2026, up 1580.0% year-over-year, with the annual reading at 23.11% for FY2025, 747.0% up from the prior year.
  • FCF Margin was 37.67% for Q1 2026 at Dexcom, up from 15.25% in the prior quarter.
  • Over five years, FCF Margin peaked at 47.91% in Q3 2025 and troughed at 4.87% in Q1 2022.
  • The 5-year median for FCF Margin is 15.25% (2025), against an average of 16.84%.
  • Year-over-year, FCF Margin crashed -1356bps in 2024 and then soared 3903bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 8.46% in 2022, then decreased by -7bps to 7.84% in 2023, then skyrocketed by 103bps to 15.88% in 2024, then decreased by -4bps to 15.25% in 2025, then soared by 147bps to 37.67% in 2026.
  • Per Business Quant, the three most recent readings for DXCM's FCF Margin are 37.67% (Q1 2026), 15.25% (Q4 2025), and 47.91% (Q3 2025).